Regenerative Medicine Market to Cross US$6.5 Billion by 2019| Key Players Dominating Market are - DePuy Synthes, Inc. (HEALOS Bone Graft), Stryker Corporation (Vitoss Bone Graft Substitute), Zimmer Holdings, Inc. (CopiOs Bone Void Filler), and Medtronic,

North America was the largest market for regenerative medicine bone and joint application in 2012, accounting for largest market share of the total regenerative medicine (bone and joint) market. The regenerative medicine market in North America witnessed significant growth due to increasing demand of bone and joint reconstructive surgeries. Moreover, favorable government initiatives have also supported the growth of the regenerative medicine bone and joint application market in this region. European market was the second largest of the global market in 2012. Rising geriatric population in European Union is one of the major market drivers in this region as the geriatric group is more prone to suffer from arthritis. Moreover, extensive support and funding provided by European government for regenerative medicine would further accentuate the market growth in this region.

Get Exclusive Year End Discounts on Report Purchase - http://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=419

Asia-Pacific was observed to be a promising market for regenerative medicine bone and joint application during the study period owing to the demand of bone graft substitute in this region. This region is considered as an emerging market and is estimated to grow at the highest CAGR from 2013 to 2019. Manufacturer of regenerative medicine bone and joint products are expanding their operation in Asian countries (India, China, Japan and South Korea) as these economies hold immense potential for regenerative medicine bone and joint application. For instance, in May 2013, Smith & Nephew acquired Sushrut Surgical Pvt. Ltd. an Indian medical technology company. Sushrut Surgicals product portfolio includes trauma implants and instruments, spine and limb salvage products. This acquisition would expand and enhance the product offerings of Smith & Nephew and would also assist in capturing lucrative market share in Asia-Pacific region. In terms of key players the global regenerative medicine bone and joint application market is highly fragmented that comprises of DePuy Synthes, Inc. (HEALOS Bone Graft), Medtronic, Inc. (INFUSE Bone Graft), Stryker Corporation (Vitoss Bone Graft Substitute) and Zimmer Holdings, Inc (CopiOs Bone Void Filler).

Regenerative medicines are an emerging field of medical science aimed at regeneration, repair, or replacement of damaged tissue and organs. As per the U.S. National Institute of Health, regenerative medicine is the procedure of creating functional tissues to repair and/or replace nonfunctional organs or tissues. With regenerative medicines, tissues or organs that have lost their functioning power due to congenital defects, age, and external or internal damage are repaired or replaced. Some of the application areas of regenerative medicines are neurology, cardiovascular, orthopedic, and musculoskeletal disorders.

Factors such as technological advancements in stem cell therapy and tissue engineering are predicted to propel the global regenerative medicine market during the forecast period. However, ethical issues, post-implantation infections and complications, and regulatory constraints are expected to hamper the growth of the global regenerative medicine market in the years to come. Leading players are focusing on capturing the untapped market to increase their share in the global market. The high number of mergers, acquisitions, and partnerships expected to occur in the coming years is predicted to make the global regenerative medicine market highly competitive in the near future.

Inquire for Exclusive Report Sample - http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=419

The global regenerative medicine market is segmented on the basis of technology, application, and geography. Based on geography, the global regenerative medicine market is divided into Asia Pacific, Europe, North America, and Rest of the World. In 2012, the global regenerative medicine market was dominated by North America due to the rising demand for bone and joint reconstructive surgeries. The region’s increasing aging population is predicted to propel the Europe regenerative medicine market in the next few years. Going forward, Asia Pacific is expected to register considerable growth in the global regenerative medicine market.

Companies such as DePuy Synthes, Inc. (HEALOS Bone Graft), Stryker Corporation (Vitoss Bone Graft Substitute), Zimmer Holdings, Inc. (CopiOs Bone Void Filler), and Medtronic, Inc. (INFUSE Bone Graft) are expected to lead the global regenerative medicine market in the years to come. The entry of new players is predicted to create new growth opportunities in the near future.

By technology, the global regenerative medicine market is classified into stem cell therapy, tissue engineering, and biomaterials. In 2012, the biomaterials segment dominated the global regenerative medicine market due to factors such as favorable reimbursement policies. Moreover, strong demand for biomaterials is predicted to propel the segment in the coming few years.

Browse Report with Complete Table of Content - http://www.transparencymarketresearch.com/regenerative-medicines-market.html

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.